Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Data from ERBB2 Induces an Antiapoptotic Expression Pattern of Bcl-2 Family Members in Node-Negative Breast Cancer

View through CrossRef
<div>Abstract<p><b>Purpose:</b> Members of the Bcl-2 family act as master regulators of mitochondrial homeostasis and apoptosis. We analyzed whether ERBB2 influences the prognosis of breast cancer by influencing the proapoptotic versus antiapoptotic balance of Bcl-2 family members.</p><p><b>Experimental Design:</b> ERBB2-regulated Bcl-2 family members were identified by inducible expression of ERBB2 in MCF-7 breast cancer cells and by correlation analysis with ERBB2 expression in breast carcinomas. The prognostic relevance of ERBB2-regulated and all additional Bcl-2 family members was determined in 782 patients with untreated node-negative breast cancer. The biological relevance of ERBB2-induced inhibition of apoptosis was validated in a murine tumor model allowing conditional ERBB2 expression.</p><p><b>Results:</b> ERBB2 caused an antiapoptotic phenotype by upregulation of <i>MCL-1, TEGT, BAG1, BNIP1,</i> and <i>BECN1</i> as well as downregulation of <i>BAX, BMF, BNIPL, CLU,</i> and <i>BCL2L13</i>. Upregulation of the antiapoptotic <i>MCL-1</i> [<i>P</i> = 0.001, hazard ratio (HR) 1.5] and <i>BNIP3</i> (<i>P</i> = 0.024; HR, 1.4) was associated with worse prognosis considering metastasis-free interval, whereas clusterin (<i>P</i> = 0.008; HR, 0.88) and the proapoptotic <i>BCL2L13</i> (<i>P</i> = 0.019; HR, 0.45) were associated with better prognosis. This indicates that ERBB2 alters the expression of Bcl-2 family members in a way that leads to adverse prognosis. Analysis of apoptosis and tumor remission in a murine tumor model confirmed that the prototypic Bcl-2 family member Bcl-x<sub>L</sub> could partially substitute for ERBB2 to antagonize tumor remission.</p><p><b>Conclusions:</b> Our results support the concept that ERBB2 influences the expression of Bcl-2 family members to induce an antiapoptotic phenotype. Antagonization of antiapoptotic Bcl-2 family members might improve breast cancer therapy, whereby MCL-1 and BNIP3 represent promising targets. Clin Cancer Res; 16(2); 451–60</p></div>
Title: Data from ERBB2 Induces an Antiapoptotic Expression Pattern of Bcl-2 Family Members in Node-Negative Breast Cancer
Description:
<div>Abstract<p><b>Purpose:</b> Members of the Bcl-2 family act as master regulators of mitochondrial homeostasis and apoptosis.
We analyzed whether ERBB2 influences the prognosis of breast cancer by influencing the proapoptotic versus antiapoptotic balance of Bcl-2 family members.
</p><p><b>Experimental Design:</b> ERBB2-regulated Bcl-2 family members were identified by inducible expression of ERBB2 in MCF-7 breast cancer cells and by correlation analysis with ERBB2 expression in breast carcinomas.
The prognostic relevance of ERBB2-regulated and all additional Bcl-2 family members was determined in 782 patients with untreated node-negative breast cancer.
The biological relevance of ERBB2-induced inhibition of apoptosis was validated in a murine tumor model allowing conditional ERBB2 expression.
</p><p><b>Results:</b> ERBB2 caused an antiapoptotic phenotype by upregulation of <i>MCL-1, TEGT, BAG1, BNIP1,</i> and <i>BECN1</i> as well as downregulation of <i>BAX, BMF, BNIPL, CLU,</i> and <i>BCL2L13</i>.
Upregulation of the antiapoptotic <i>MCL-1</i> [<i>P</i> = 0.
001, hazard ratio (HR) 1.
5] and <i>BNIP3</i> (<i>P</i> = 0.
024; HR, 1.
4) was associated with worse prognosis considering metastasis-free interval, whereas clusterin (<i>P</i> = 0.
008; HR, 0.
88) and the proapoptotic <i>BCL2L13</i> (<i>P</i> = 0.
019; HR, 0.
45) were associated with better prognosis.
This indicates that ERBB2 alters the expression of Bcl-2 family members in a way that leads to adverse prognosis.
Analysis of apoptosis and tumor remission in a murine tumor model confirmed that the prototypic Bcl-2 family member Bcl-x<sub>L</sub> could partially substitute for ERBB2 to antagonize tumor remission.
</p><p><b>Conclusions:</b> Our results support the concept that ERBB2 influences the expression of Bcl-2 family members to induce an antiapoptotic phenotype.
Antagonization of antiapoptotic Bcl-2 family members might improve breast cancer therapy, whereby MCL-1 and BNIP3 represent promising targets.
Clin Cancer Res; 16(2); 451–60</p></div>.

Related Results

Hubungan Perilaku Pola Makan dengan Kejadian Anak Obesitas
Hubungan Perilaku Pola Makan dengan Kejadian Anak Obesitas
<p><em><span style="font-size: 11.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-langua...
ERBB2 Induces an Antiapoptotic Expression Pattern of Bcl-2 Family Members in Node-Negative Breast Cancer
ERBB2 Induces an Antiapoptotic Expression Pattern of Bcl-2 Family Members in Node-Negative Breast Cancer
Abstract Purpose: Members of the Bcl-2 family act as master regulators of mitochondrial homeostasis and apoptosis. We analyzed whether ERBB2 influences the progno...
Data from ERBB2 Induces an Antiapoptotic Expression Pattern of Bcl-2 Family Members in Node-Negative Breast Cancer
Data from ERBB2 Induces an Antiapoptotic Expression Pattern of Bcl-2 Family Members in Node-Negative Breast Cancer
<div>Abstract<p><b>Purpose:</b> Members of the Bcl-2 family act as master regulators of mitochondrial homeostasis and apoptosis. We analyzed whether ERBB2 i...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Predictors of False-Negative Axillary FNA Among Breast Cancer Patients: A Cross-Sectional Study
Predictors of False-Negative Axillary FNA Among Breast Cancer Patients: A Cross-Sectional Study
Abstract Introduction Fine-needle aspiration (FNA) is commonly used to investigate lymphadenopathy of suspected metastatic origin. The current study aims to find the association be...
Coexisting Granulomatous Mastitis and Breast Cancer: A Systematic Review
Coexisting Granulomatous Mastitis and Breast Cancer: A Systematic Review
Abstract Introduction: Granulomatous mastitis (GM) is a rare inflammatory breast disease that mimics carcinoma. GM can coexist with breast cancer (BC), though the relationship rema...

Back to Top